<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37055492</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>13</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Sex and age affect acute and persisting COVID-19 illness.</ArticleTitle><Pagination><StartPage>6029</StartPage><MedlinePgn>6029</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6029</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-33150-x</ELocationID><Abstract><AbstractText>Long COVID is associated with neurological and neuropsychiatric manifestations. We conducted an observational study on 97 patients with prior SARS-CoV-2 infection and persisting cognitive complaints that presented to the University Health Network Memory Clinic between October 2020 and December 2021. We assessed the main effects of sex, age, and their interaction on COVID-19 symptoms and outcomes. We also examined the relative contribution of demographics and acute COVID-19 presentation (assessed retrospectively) on persistent neurological symptoms and cognition. Among our cohort, males had higher hospitalization rates than females during the acute COVID-19 illness (18/35 (51%) vs. 15/62 (24%); P&#x2009;=&#x2009;.009). Abnormal scores on cognitive assessments post-COVID were associated with older age (AOR&#x2009;=&#x2009;0.84; 95% CI 0.74-0.93) and brain fog during initial illness (AOR&#x2009;=&#x2009;8.80; 95% CI 1.76-65.13). Female sex (ARR&#x2009;=&#x2009;1.42; 95% CI 1.09-1.87) and acute shortness of breath (ARR&#x2009;=&#x2009;1.41; 95% CI 1.09-1.84) were associated with a higher risk of experiencing more persistent short-term memory symptoms. Female sex was the only predictor associated with persistent executive dysfunction (ARR&#x2009;=&#x2009;1.39; 95% CI 1.12-1.76) and neurological symptoms (ARR&#x2009;=&#x2009;1.66; 95% CI 1.19-2.36). Sex differences were evident in presentations and cognitive outcomes in patients with long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasilevskaya</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St. WW5-449, Toronto, ON, M5T 2S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mushtaque</LastName><ForeName>Asma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St. WW5-449, Toronto, ON, M5T 2S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Michelle Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St. WW5-449, Toronto, ON, M5T 2S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwazan</LastName><ForeName>Batoul</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St. WW5-449, Toronto, ON, M5T 2S8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Board, Kuwait Institution for Medical Specialty (KIMS), Andalous, Kuwait.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herridge</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartaglia</LastName><ForeName>Maria Carmela</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada. carmela.tartaglia@uhn.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada. carmela.tartaglia@uhn.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St. WW5-449, Toronto, ON, M5T 2S8, Canada. carmela.tartaglia@uhn.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada. carmela.tartaglia@uhn.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000554" MajorTopicYN="N">Ambulatory Care Facilities</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37055492</ArticleId><ArticleId IdType="pmc">PMC10098246</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-33150-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-33150-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int.</Citation></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M, et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed. Pharmacother. 2020;131:110678. doi: 10.1016/j.biopha.2020.110678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110678</ArticleId><ArticleId IdType="pmc">PMC7444942</ArticleId><ArticleId IdType="pubmed">32861070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J. Clin. Virol. 2020;127:104371. doi: 10.1016/j.jcv.2020.104371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104371</ArticleId><ArticleId IdType="pmc">PMC7195434</ArticleId><ArticleId IdType="pubmed">32315817</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0250602. doi: 10.1371/journal.pone.0250602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0250602</ArticleId><ArticleId IdType="pmc">PMC8092779</ArticleId><ArticleId IdType="pubmed">33939733</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Rolain J-M, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J. Microbiol. Immunol. Infect. 2020;53:425&#x2013;435. doi: 10.1016/j.jmii.2020.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7201239</ArticleId><ArticleId IdType="pubmed">32414646</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F, et al. Neurological and cognitive sequelae of Covid-19: A four month follow-up. J. Neurol. 2021;268:4422&#x2013;4428. doi: 10.1007/s00415-021-10579-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10579-6</ArticleId><ArticleId IdType="pmc">PMC8088203</ArticleId><ArticleId IdType="pubmed">33932157</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao F, et al. A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities. Transl. Psychiatry. 2020;10:355. doi: 10.1038/s41398-020-01039-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-01039-2</ArticleId><ArticleId IdType="pmc">PMC7570419</ArticleId><ArticleId IdType="pubmed">33077738</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 &#x2013; A systematic review. Brain Behav. Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghdiri F, et al. Decreased number of self-paced saccades in post-concussion syndrome associated with higher symptom burden and reduced white matter integrity. J. Neurotrauma. 2018;35:719&#x2013;729. doi: 10.1089/neu.2017.5274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5274</ArticleId><ArticleId IdType="pubmed">29239265</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman M, et al. The toronto cognitive assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment. Alzheimer&#x2019;s Res. Ther. 2018;10:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052695</ArticleId><ArticleId IdType="pubmed">30021658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsblom E, et al. Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area&#x2013;a population-based registry study. Infect. Dis. 2021;53:789&#x2013;799. doi: 10.1080/23744235.2021.1936157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1936157</ArticleId><ArticleId IdType="pubmed">34100692</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapp JL, Lieberman-Cribbin W, Tuminello S, Taioli E. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City. Chest. 2021;159:112&#x2013;115. doi: 10.1016/j.chest.2020.08.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.08.2065</ArticleId><ArticleId IdType="pmc">PMC7455228</ArticleId><ArticleId IdType="pubmed">32866462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi MC, Tieri P, Ortona E, Ruggieri A. ACE2 expression and sex disparity in COVID-19. Cell Death Discov. 2020;6:1&#x2013;2. doi: 10.1038/s41420-020-0276-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-0276-1</ArticleId><ArticleId IdType="pmc">PMC7248455</ArticleId><ArticleId IdType="pubmed">32499922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook, J. R. &amp; Ausiello, J. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19. Rev. Endocr. Metab. Disord. 1&#x2013;20 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245275</ArticleId><ArticleId IdType="pubmed">34195965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors&#x2014;Lessons from available evidence and insights into COVID-19. Hypertens. Res. 2020;43:648&#x2013;654. doi: 10.1038/s41440-020-0455-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0455-8</ArticleId><ArticleId IdType="pmc">PMC7184165</ArticleId><ArticleId IdType="pubmed">32341442</ArticleId></ArticleIdList></Reference><Reference><Citation>Banu N, Panikar SS, Leal LR, Leal AR. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: Therapeutic implications. Life Sci. 2020;256:117905. doi: 10.1016/j.lfs.2020.117905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117905</ArticleId><ArticleId IdType="pmc">PMC7832382</ArticleId><ArticleId IdType="pubmed">32504757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28(611):e9&#x2013;611.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: A living systematic review. BMJ Glob Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, et al. Long COVID-19: Objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9(2):141&#x2013;154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, et al. Long-term cognitive impairment after critical illness. N. Engl. J. Med. 2013;369:1306&#x2013;1316. doi: 10.1056/NEJMoa1301372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301372</ArticleId><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F, et al. Critical illness-associated cerebral microbleeds for patients with severe COVID-19: Etiologic hypotheses. J. Neurol. 2021;268:2676&#x2013;2684. doi: 10.1007/s00415-020-10313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10313-8</ArticleId><ArticleId IdType="pmc">PMC7679237</ArticleId><ArticleId IdType="pubmed">33219827</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson JC, Hunt CH, Klaas JP, Kallmes DF. Intracranial microhemorrhages in the setting of COVID-19: What we know so far. Neuroradiol. J. 2021;34:435&#x2013;439. doi: 10.1177/19714009211004144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19714009211004144</ArticleId><ArticleId IdType="pmc">PMC8559007</ArticleId><ArticleId IdType="pubmed">33765876</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L, et al. Cerebral microhaemorrhage in COVID-19: A critical illness related phenomenon? Stroke Vasc. Neurol. 2020;5:e000652. doi: 10.1136/svn-2020-000652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000652</ArticleId><ArticleId IdType="pmc">PMC7681795</ArticleId><ArticleId IdType="pubmed">33208493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanou EM, et al. Critical illness&#x2013;associated cerebral microbleeds. Stroke. 2017;48:1085&#x2013;1087. doi: 10.1161/STROKEAHA.116.016289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.016289</ArticleId><ArticleId IdType="pubmed">28235962</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020;87:34&#x2013;39. doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans. Sci. Rep. 2021;11:6481. doi: 10.1038/s41598-021-85943-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85943-7</ArticleId><ArticleId IdType="pmc">PMC7979938</ArticleId><ArticleId IdType="pubmed">33742072</ArticleId></ArticleIdList></Reference><Reference><Citation>Shnayder NA, Sirbiladze TK, Demko IV, Petrova MM, Nasyrova RF. Limbic encephalitis associated with COVID-19. Encyclopedia. 2022;2:26&#x2013;35. doi: 10.3390/encyclopedia2010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/encyclopedia2010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Seda G, Han TS. Effect of obstructive sleep apnea on neurocognitive performance. Sleep Med. Clin. 2020;15:77&#x2013;85. doi: 10.1016/j.jsmc.2019.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsmc.2019.10.001</ArticleId><ArticleId IdType="pubmed">32005352</ArticleId></ArticleIdList></Reference><Reference><Citation>Billaut F, Gueit P, Faure S, Costalat G, Lema&#xee;tre F. Do elite breath-hold divers suffer from mild short-term memory impairments? Appl. Physiol. Nutr. Metab. 2018;43:247&#x2013;251. doi: 10.1139/apnm-2017-0245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/apnm-2017-0245</ArticleId><ArticleId IdType="pubmed">29053942</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondaine T, et al. Long-term cognitive impairments following COVID-19: A possible impact of hypoxia. J. Neurol. 2022 doi: 10.1007/s00415-022-11077-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11077-z</ArticleId><ArticleId IdType="pmc">PMC8944178</ArticleId><ArticleId IdType="pubmed">35325308</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer&#x2019;s dementia. Alzheimer&#x2019;s Dement. 2022;8(5):899&#x2013;910. doi: 10.1002/alz.12556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12556</ArticleId><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, et al. Amyloid processing in COVID-19-associated neurological syndromes. J. Neurochem. 2022;161:146&#x2013;157. doi: 10.1111/jnc.15585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15585</ArticleId><ArticleId IdType="pmc">PMC9115071</ArticleId><ArticleId IdType="pubmed">35137414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Zhang X, Huang Z, Ma K. SARS-CoV-2 proteins interact with alpha synuclein and induce lewy body-like pathology in vitro. Int. J. Mol. Sci. 2022;23:3394. doi: 10.3390/ijms23063394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063394</ArticleId><ArticleId IdType="pmc">PMC8949667</ArticleId><ArticleId IdType="pubmed">35328814</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Mittal S, Roy R. Parkinson&#x2019;s disease and the COVID-19 pandemic: A review article on the association between SARS-CoV-2 and &#x3b1;-synucleinopathy. J. Mov. Disord. 2021;14:184&#x2013;192. doi: 10.14802/jmd.21046.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.21046</ArticleId><ArticleId IdType="pmc">PMC8490193</ArticleId><ArticleId IdType="pubmed">34315206</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademian F, Delavari S, Koohjani Z, Khademian Z. An investigation of depression, anxiety, and stress and its relating factors during COVID-19 pandemic in Iran. BMC Public Health. 2021;21:275. doi: 10.1186/s12889-021-10329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10329-3</ArticleId><ArticleId IdType="pmc">PMC7856614</ArticleId><ArticleId IdType="pubmed">33535992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud S, Hossain S, Muyeed A, Islam MM, Mohsin Md. The global prevalence of depression, anxiety, stress, and insomnia and its changes among health professionals during COVID-19 pandemic: A rapid systematic review and meta-analysis. Heliyon. 2021;7:e07393. doi: 10.1016/j.heliyon.2021.e07393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e07393</ArticleId><ArticleId IdType="pmc">PMC8261554</ArticleId><ArticleId IdType="pubmed">34278018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bareeqa SB, et al. Prevalence of depression, anxiety and stress in china during COVID-19 pandemic: A systematic review with meta-analysis. Int. J. Psychiatry Med. 2021;56:210&#x2013;227. doi: 10.1177/0091217420978005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0091217420978005</ArticleId><ArticleId IdType="pubmed">33243029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhan R, Agrawal A, Sharma M. Prevalence of depression, anxiety, and stress during COVID-19 pandemic. J. Neurosci. Rural Pract. 2020;11:519&#x2013;525. doi: 10.1055/s-0040-1716442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1716442</ArticleId><ArticleId IdType="pmc">PMC7595780</ArticleId><ArticleId IdType="pubmed">33144785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>